Literature DB >> 26845400

An eye to the future: Researchers debate best path for stem cell-derived therapies.

Shraddha Chakradhar1.   

Abstract

Mesh:

Year:  2016        PMID: 26845400     DOI: 10.1038/nm0216-116

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  1 in total

1.  Treatment of macular degeneration using embryonic stem cell-derived retinal pigment epithelium: preliminary results in Asian patients.

Authors:  Won Kyung Song; Kyung-Mi Park; Hyun-Ju Kim; Jae Ho Lee; Jinjung Choi; So Young Chong; Sung Han Shim; Lucian V Del Priore; Robert Lanza
Journal:  Stem Cell Reports       Date:  2015-04-30       Impact factor: 7.765

  1 in total
  16 in total

1.  Generation of Xeno-Free, cGMP-Compliant Patient-Specific iPSCs from Skin Biopsy.

Authors:  Luke A Wiley; Kristin R Anfinson; Cathryn M Cranston; Emily E Kaalberg; Malia M Collins; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Curr Protoc Stem Cell Biol       Date:  2017-08-14

Review 2.  Recent Advances in Age-Related Macular Degeneration Therapies.

Authors:  Marie Fabre; Lou Mateo; Diana Lamaa; Stéphanie Baillif; Gilles Pagès; Luc Demange; Cyril Ronco; Rachid Benhida
Journal:  Molecules       Date:  2022-08-10       Impact factor: 4.927

Review 3.  Myocardial regeneration protocols towards the routine clinical scenario: An unseemly path from bench to bedside.

Authors:  Nadia Salerno; Luca Salerno; Fabiola Marino; Mariangela Scalise; Antonio Chiefalo; Giuseppe Panuccio; Antonella De Angelis; Eleonora Cianflone; Konrad Urbanek; Daniele Torella
Journal:  EClinicalMedicine       Date:  2022-06-27

4.  Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease.

Authors:  Agnete Kirkeby; Sara Nolbrant; Katarina Tiklova; Andreas Heuer; Nigel Kee; Tiago Cardoso; Daniella Rylander Ottosson; Mariah J Lelos; Pedro Rifes; Stephen B Dunnett; Shane Grealish; Thomas Perlmann; Malin Parmar
Journal:  Cell Stem Cell       Date:  2016-10-27       Impact factor: 24.633

5.  Cell therapies for Parkinson's disease: how far have we come?

Authors:  Thomas B Stoker; Roger A Barker
Journal:  Regen Med       Date:  2016-11-25       Impact factor: 3.806

Review 6.  Genomic Instability of iPSCs: Challenges Towards Their Clinical Applications.

Authors:  Masahito Yoshihara; Yoshihide Hayashizaki; Yasuhiro Murakawa
Journal:  Stem Cell Rev Rep       Date:  2017-02       Impact factor: 5.739

Review 7.  The translational potential of human induced pluripotent stem cells for clinical neurology : The translational potential of hiPSCs in neurology.

Authors:  Helen Devine; Rickie Patani
Journal:  Cell Biol Toxicol       Date:  2016-12-03       Impact factor: 6.691

Review 8.  Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD).

Authors:  Mark Fields; Hui Cai; Jie Gong; Lucian Del Priore
Journal:  Cells       Date:  2016-12-08       Impact factor: 6.600

9.  hESC-derived immune suppressive dendritic cells induce immune tolerance of parental hESC-derived allografts.

Authors:  Dilyana Todorova; Yue Zhang; Qu Chen; Jingfeng Liu; Jingjin He; Xuemei Fu; Yang Xu
Journal:  EBioMedicine       Date:  2020-11-23       Impact factor: 8.143

Review 10.  Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy with Induced Pluripotent Stem Cells.

Authors:  Felipe Arroyave; Diana Montaño; Fernando Lizcano
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.